Apogee Therapeutics Inc. (APGE)
(Delayed Data from NSDQ)
$38.33 USD
+1.09 (2.93%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $38.28 -0.05 (-0.13%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Apogee Therapeutics Inc. has a market cap of $1.71B, which represents its share price of $37.24 multiplied by its outstanding shares number of 46.05M. As a small-cap company, APGE's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
APGE 38.33 +1.09(2.93%)
Will APGE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for APGE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APGE
Wall Street Analysts See a 129.09% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?
Wall Street Analysts Think Apogee Therapeutics Inc. (APGE) Could Surge 132.72%: Read This Before Placing a Bet
APGE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Believe Apogee Therapeutics Inc. (APGE) Could Rally 134%: Here's is How to Trade
Other News for APGE
BTIG Increases Price Target for Apogee Therapeutics (APGE) to $115 | APGE Stock News
Apogee Therapeutics price target raised by $15 at BTIG, here's why
Gold Falls 1%; ProKidney Shares Spike Higher
Apogee Therapeutics: Funding Supports Best-In-Class Ambitions In Atopic Dermatitis
12 Health Care Stocks Moving In Monday's Intraday Session